Clanker co-founder Jack Dishman will leave the project
Foresight News reported that Clanker co-founder Jack Dishman will leave the project and will no longer continue development. "Building this project taught me what it takes to create something people truly care about, and how to operate systems at scale. I look forward to seeing how Clanker evolves in the future with the support of the Farcaster team and the Clanker Ecosystem Fund."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
London Gold and Silver Vault Data for September 2026
Bristol-Myers Squibb (BMY.US) rises in pre-market trading! Two experimental drugs report positive results in Phase 3 clinical trials, diversifying and accelerating the pipeline
Bristol Myers Squibb's two experimental drugs, used to treat a rare endocrine cancer and a deadly lung disease, have achieved success in Phase III clinical trials, injecting momentum into the pharmaceutical company’s new product pipeline.
